- Home
- ABEO vs PINE Comparison
ABEO vs PINE Comparison
Compare ABEO & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | PINE |
|---|---|---|
| Founded | 1974 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 277.5M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABEO | PINE |
|---|---|---|
| Price | $5.82 | $19.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $20.00 | ★ $20.10 |
| AVG Volume (30 Days) | ★ 1.1M | 139.8K |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 6.29% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $2,998,000.00 | ★ $60,532,000.00 |
| Revenue This Year | $1,024.31 | $18.63 |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | ★ N/A | $317.00 |
| Revenue Growth | ★ 258.18 | 15.90 |
| 52 Week Low | $4.00 | $13.10 |
| 52 Week High | $7.54 | $20.80 |
Technical Indicators
Market Signals| Indicator | ABEO | PINE |
|---|---|---|
| Relative Strength Index (RSI) | 58.15 | 49.59 |
| Support Level | $4.91 | $18.72 |
| Resistance Level | $6.07 | $19.98 |
| Average True Range (ATR) | 0.23 | 0.40 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 86.13 | 46.85 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.